Report Thumbnail
Product Code LP09141104837JB
Published Date 2024/2/16
English108 PagesGlobal

Global Pulmonary Devices Market Growth 2024-2030MedicalDevice_MedTech Market


Report Thumbnail
Product Code LP09141104837JB◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/2/16
English 108 PagesGlobal

Global Pulmonary Devices Market Growth 2024-2030MedicalDevice_MedTech Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global Pulmonary Devices market size was valued at US$ 8183.1 million in 2023. With growing demand in downstream market, the Pulmonary Devices is forecast to a readjusted size of US$ 12920 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Pulmonary Devices market. Pulmonary Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pulmonary Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pulmonary Devices market.
Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. 
Factors such as increase in prevalence of respiratory diseases, rise in geriatric population, sedentary lifestyle, high prevalence of smoking, growth in pollution levels, and urbanization drive the market growth. 
Key Features:
The report on Pulmonary Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pulmonary Devices market. It may include historical data, market segmentation by Type (e.g., Therapeutic Devices, Diagnostic Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pulmonary Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pulmonary Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pulmonary Devices industry. This include advancements in Pulmonary Devices technology, Pulmonary Devices new entrants, Pulmonary Devices new investment, and other innovations that are shaping the future of Pulmonary Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pulmonary Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Pulmonary Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pulmonary Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pulmonary Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pulmonary Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pulmonary Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pulmonary Devices market.
Market Segmentation:
Pulmonary Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Therapeutic Devices
Diagnostic Devices
Monitoring Devices
Segmentation by application
Hospitals
Ambulatory Care
Home Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Glaxosmithkline
3M Company
Medtronic
Koninklijke Philips
Resmed
Masimo Corporation
Thermo Fisher Scientific
Fisher and Paykel Healthcare
Becton, Dickinson and Company
Hamilton Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pulmonary Devices market?
What factors are driving Pulmonary Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Devices market opportunities vary by end market size?
How does Pulmonary Devices break out type, application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Pulmonary Devices Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Pulmonary Devices by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Pulmonary Devices by Country/Region, 2019, 2023 & 2030
    • 2.2 Pulmonary Devices Segment by Type
      • 2.2.1 Therapeutic Devices
      • 2.2.2 Diagnostic Devices
      • 2.2.3 Monitoring Devices
    • 2.3 Pulmonary Devices Sales by Type
      • 2.3.1 Global Pulmonary Devices Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Pulmonary Devices Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Pulmonary Devices Sale Price by Type (2019-2024)
    • 2.4 Pulmonary Devices Segment by Application
      • 2.4.1 Hospitals
      • 2.4.2 Ambulatory Care
      • 2.4.3 Home Care
    • 2.5 Pulmonary Devices Sales by Application
      • 2.5.1 Global Pulmonary Devices Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Pulmonary Devices Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Pulmonary Devices Sale Price by Application (2019-2024)
  • 3 Global Pulmonary Devices by Company

    • 3.1 Global Pulmonary Devices Breakdown Data by Company
      • 3.1.1 Global Pulmonary Devices Annual Sales by Company (2019-2024)
      • 3.1.2 Global Pulmonary Devices Sales Market Share by Company (2019-2024)
    • 3.2 Global Pulmonary Devices Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Pulmonary Devices Revenue by Company (2019-2024)
      • 3.2.2 Global Pulmonary Devices Revenue Market Share by Company (2019-2024)
    • 3.3 Global Pulmonary Devices Sale Price by Company
    • 3.4 Key Manufacturers Pulmonary Devices Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Pulmonary Devices Product Location Distribution
      • 3.4.2 Players Pulmonary Devices Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Pulmonary Devices by Geographic Region

    • 4.1 World Historic Pulmonary Devices Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Pulmonary Devices Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Pulmonary Devices Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Pulmonary Devices Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Pulmonary Devices Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Pulmonary Devices Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Pulmonary Devices Sales Growth
    • 4.4 APAC Pulmonary Devices Sales Growth
    • 4.5 Europe Pulmonary Devices Sales Growth
    • 4.6 Middle East & Africa Pulmonary Devices Sales Growth
  • 5 Americas

    • 5.1 Americas Pulmonary Devices Sales by Country
      • 5.1.1 Americas Pulmonary Devices Sales by Country (2019-2024)
      • 5.1.2 Americas Pulmonary Devices Revenue by Country (2019-2024)
    • 5.2 Americas Pulmonary Devices Sales by Type
    • 5.3 Americas Pulmonary Devices Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Pulmonary Devices Sales by Region
      • 6.1.1 APAC Pulmonary Devices Sales by Region (2019-2024)
      • 6.1.2 APAC Pulmonary Devices Revenue by Region (2019-2024)
    • 6.2 APAC Pulmonary Devices Sales by Type
    • 6.3 APAC Pulmonary Devices Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Pulmonary Devices by Country
      • 7.1.1 Europe Pulmonary Devices Sales by Country (2019-2024)
      • 7.1.2 Europe Pulmonary Devices Revenue by Country (2019-2024)
    • 7.2 Europe Pulmonary Devices Sales by Type
    • 7.3 Europe Pulmonary Devices Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Pulmonary Devices by Country
      • 8.1.1 Middle East & Africa Pulmonary Devices Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Pulmonary Devices Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Pulmonary Devices Sales by Type
    • 8.3 Middle East & Africa Pulmonary Devices Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Pulmonary Devices
    • 10.3 Manufacturing Process Analysis of Pulmonary Devices
    • 10.4 Industry Chain Structure of Pulmonary Devices
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Pulmonary Devices Distributors
    • 11.3 Pulmonary Devices Customer
  • 12 World Forecast Review for Pulmonary Devices by Geographic Region

    • 12.1 Global Pulmonary Devices Market Size Forecast by Region
      • 12.1.1 Global Pulmonary Devices Forecast by Region (2025-2030)
      • 12.1.2 Global Pulmonary Devices Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Pulmonary Devices Forecast by Type
    • 12.7 Global Pulmonary Devices Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Glaxosmithkline
      • 13.1.1 Glaxosmithkline Company Information
      • 13.1.2 Glaxosmithkline Pulmonary Devices Product Portfolios and Specifications
      • 13.1.3 Glaxosmithkline Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 Glaxosmithkline Main Business Overview
      • 13.1.5 Glaxosmithkline Latest Developments
    • 13.2 3M Company
      • 13.2.1 3M Company Company Information
      • 13.2.2 3M Company Pulmonary Devices Product Portfolios and Specifications
      • 13.2.3 3M Company Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 3M Company Main Business Overview
      • 13.2.5 3M Company Latest Developments
    • 13.3 Medtronic
      • 13.3.1 Medtronic Company Information
      • 13.3.2 Medtronic Pulmonary Devices Product Portfolios and Specifications
      • 13.3.3 Medtronic Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 Medtronic Main Business Overview
      • 13.3.5 Medtronic Latest Developments
    • 13.4 Koninklijke Philips
      • 13.4.1 Koninklijke Philips Company Information
      • 13.4.2 Koninklijke Philips Pulmonary Devices Product Portfolios and Specifications
      • 13.4.3 Koninklijke Philips Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 Koninklijke Philips Main Business Overview
      • 13.4.5 Koninklijke Philips Latest Developments
    • 13.5 Resmed
      • 13.5.1 Resmed Company Information
      • 13.5.2 Resmed Pulmonary Devices Product Portfolios and Specifications
      • 13.5.3 Resmed Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 Resmed Main Business Overview
      • 13.5.5 Resmed Latest Developments
    • 13.6 Masimo Corporation
      • 13.6.1 Masimo Corporation Company Information
      • 13.6.2 Masimo Corporation Pulmonary Devices Product Portfolios and Specifications
      • 13.6.3 Masimo Corporation Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 Masimo Corporation Main Business Overview
      • 13.6.5 Masimo Corporation Latest Developments
    • 13.7 Thermo Fisher Scientific
      • 13.7.1 Thermo Fisher Scientific Company Information
      • 13.7.2 Thermo Fisher Scientific Pulmonary Devices Product Portfolios and Specifications
      • 13.7.3 Thermo Fisher Scientific Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 Thermo Fisher Scientific Main Business Overview
      • 13.7.5 Thermo Fisher Scientific Latest Developments
    • 13.8 Fisher and Paykel Healthcare
      • 13.8.1 Fisher and Paykel Healthcare Company Information
      • 13.8.2 Fisher and Paykel Healthcare Pulmonary Devices Product Portfolios and Specifications
      • 13.8.3 Fisher and Paykel Healthcare Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.8.4 Fisher and Paykel Healthcare Main Business Overview
      • 13.8.5 Fisher and Paykel Healthcare Latest Developments
    • 13.9 Becton, Dickinson and Company
      • 13.9.1 Becton, Dickinson and Company Company Information
      • 13.9.2 Becton, Dickinson and Company Pulmonary Devices Product Portfolios and Specifications
      • 13.9.3 Becton, Dickinson and Company Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.9.4 Becton, Dickinson and Company Main Business Overview
      • 13.9.5 Becton, Dickinson and Company Latest Developments
    • 13.10 Hamilton Medical
      • 13.10.1 Hamilton Medical Company Information
      • 13.10.2 Hamilton Medical Pulmonary Devices Product Portfolios and Specifications
      • 13.10.3 Hamilton Medical Pulmonary Devices Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.10.4 Hamilton Medical Main Business Overview
      • 13.10.5 Hamilton Medical Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.